www.aging-us.com AGING 2021, Vol. 13, No. 2 Research Paper Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma Xin Yuan1, Ya Li1, An Zhi Zhang1, Chen Hao Jiang1, Fan Ping Li1, Yu Fang Xie1, Jiang Fen Li1, Wei Hua Liang1, Hai Jun Zhang1, Chun Xia Liu1, Li Juan Pang1, Xi Hua Shen1, Feng Li1,2, Jian Ming Hu1 1Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases (Ministry of Education), Department of Pathology, The First Affiliated Hospital, Shihezi University School of Medicine, Xinjiang 832000, China 2Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China Correspondence to: Jian Ming Hu; email:
[email protected], https://orcid.org/0000-0001-7790-7979 Keywords: tumour-associated macrophage, FGL2, esophageal carcinoma, immunotherapy, tumour-infiltrating Received: July 17, 2020 Accepted: October 22, 2020 Published: December 15, 2020 Copyright: © 2020 Yuan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT The immune response facilitated by tumor-associated macrophages is a vital determinant of tumor progression. We identified differentially expressed genes between various macrophage phenotypes in the Gene Expression Omnibus, and used Kaplan-Meier Plotter to determine which of them altered the prognosis of esophageal carcinoma patients. Fibrinogen-like protein 2 (FGL2), an immunosuppressive factor in the tumor microenvironment of various cancers, was upregulated in M2 macrophages, and higher FGL2 expression was associated with poorer survival in esophageal carcinoma patients.